211 related articles for article (PubMed ID: 32700733)
1. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Kawashima H; Kawai A; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Oct; 50(11):1274-1281. PubMed ID: 32700733
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
3. Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis.
Ananth P; Werger A; Voss S; Rodriguez-Galindo C; Janeway KA
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27905688
[TBL] [Abstract][Full Text] [Related]
4. Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.
Koike H; Hamada S; Sakai T; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1032-1036. PubMed ID: 32533161
[TBL] [Abstract][Full Text] [Related]
5. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
6. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Eur J Cancer; 2009 Nov; 45(17):2930-4. PubMed ID: 19767198
[TBL] [Abstract][Full Text] [Related]
7. Response of progressive fibromatosis to therapy with liposomal doxorubicin.
Wehl G; Rossler J; Otten JE; Boehm N; Uhl M; Kontny U; Niemeyer C
Onkologie; 2004 Dec; 27(6):552-6. PubMed ID: 15591714
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review.
Emori M; Matsumoto Y; Murahashi Y; Yoshida M; Nishida Y
Nagoya J Med Sci; 2021 Nov; 83(4):673-681. PubMed ID: 34916712
[TBL] [Abstract][Full Text] [Related]
9. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
10. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.
Eastley N; McCulloch T; Esler C; Hennig I; Fairbairn J; Gronchi A; Ashford R
Eur J Surg Oncol; 2016 Jul; 42(7):1071-83. PubMed ID: 26965303
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of surgical treatment for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis: a systematic review and meta-analysis.
Kito M; Ogose A; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 May; 50(5):574-580. PubMed ID: 32115631
[TBL] [Abstract][Full Text] [Related]
13. Intestinal perforation during chemotherapeutic treatment of intra-abdominal desmoid tumor in patients with Gardner's syndrome: report of two cases.
Li W; Zhou Y; Li Q; Tong H; Lu W
World J Surg Oncol; 2016 Jul; 14(1):178. PubMed ID: 27377916
[TBL] [Abstract][Full Text] [Related]
14. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
15. Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
Oh CR; Jeong H; Kim W; Lee JS; Song SY; Song JS; Cho KJ; Chung HW; Lee MH; Hong JY; Lee J; Kim JE; Ahn JH
Int J Clin Oncol; 2024 Jun; 29(6):853-861. PubMed ID: 38526622
[TBL] [Abstract][Full Text] [Related]
16. Desmoid-type fibromatosis: toward a holistic management.
Penel N; Kasper B; van Der Graaf WTA
Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy in adult desmoid tumors.
Patel SR; Evans HL; Benjamin RS
Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
[TBL] [Abstract][Full Text] [Related]
18. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-Eluting Intra-Arterial Therapy for Pediatric Extra-Abdominal Desmoid Fibromatoses: A Promising Approach for a Perplexing Disease.
Elnekave E; Atar E; Amar S; Bruckheimer E; Knizhnik M; Yaniv I; Dujovny T; Feinmesser M; Ash S
J Vasc Interv Radiol; 2018 Oct; 29(10):1376-1382. PubMed ID: 30075974
[TBL] [Abstract][Full Text] [Related]
20. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
Gega M; Yanagi H; Yoshikawa R; Noda M; Ikeuchi H; Tsukamoto K; Oshima T; Fujiwara Y; Gondo N; Tamura K; Utsunomiya J; Hashimoto-Tamaoki T; Yamamura T
J Clin Oncol; 2006 Jan; 24(1):102-5. PubMed ID: 16382119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
